Dudediligence.

Vertex Pharmaceuticals Incorporated

VRTXNASDAQ · Pharmaceutical Preparations
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 1 →InsidersNo open-market buys. 13 insiders sold $155.8M, all 89 sales on a 10b5-1 plan.→HoldersCapital World Investors 10.3%BlackRock 9.5%Capital Research Global Investors 7.7%→PeersClosest companies: BIIB, INCY, IONS→

From the filings

Figures

Revenue
$12.59Blast 12 months
Net income
$4.41Blast 12 months
Operating cash flow
$4.24Blast 12 months
Cash and equivalents
$6.14Bat the last balance sheet
Shares outstanding
253.3M shareson issue
Every year and quarter →